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Rationale: The respiratory epithelium has a remarkable capacity to
respond to acute injury. In contrast, repeated epithelial injury is
often associated with abnormal repair, inflammation, and fibrosis.
There is increasing evidence that nonciliated epithelial cells play
important roles in the repair of the bronchiolar epithelium after
acute injury. Cellular processes underlying the repair and remodel-
ing of the lung after chronic epithelial injury are poorly understood.
Objectives: To identify cell processes mediating epithelial regenera-
tion and remodeling after acute and chronic Clara cell depletion.
Methods: A transgenic mouse model was generated to conditionally
express diphtheria toxin A to ablate Clara cells in the adult lung.
Epithelial regeneration and peribronchiolar fibrosis were assessed
after acute and chronic Clara cell depletion.
Measurements and Main Results: Acute Clara cell ablation caused
squamous metaplasia of ciliated cells and induced proliferation of
residual progenitor cells. Ciliated cells in the bronchioles and pro–
surfactantproteinC–expressingcells in thebronchiolar alveolarduct
junctions did not proliferate. Epithelial cell proliferation occurred at
multiple sites along the airways and was not selectively associated
with regions around neuroepithelial bodies. Chronic Clara cell de-
pletion resulted in ineffective repair and caused peribronchiolar
fibrosis.
Conclusions: Colocalization of proliferation and cell type–specific
markers demonstrate that Clara cells are critical airway progenitor
cells. Continuous depletion of Clara cells resulted in persistent
squamous metaplasia, lack of normal reepithelialization, and peri-
bronchiolar fibrosis. Induction of proliferation in subepithelial fibro-
blasts supports the concept that chronic epithelial depletion caused
peribronchiolar fibrosis.
Keywords: chronic obstructive pulmonary disease; bronchiolitis oblit-
erans syndrome; squamous metaplasia; diphtheria toxin; progenitor
cells
After an acute injury the respiratory epithelium is capable of
remarkable regeneration without remodeling or fibrosis. The
importance of nonciliated bronchiolar epithelial cells (Clara
cells) in the peripheral airways and basal cells in the cartilag-
inous airways in repair after acute injury has been supported by
findings in mouse models (1–8). It remains unclear whether all
Clara cells, or only restricted subpopulations, have the capacity
to self-renew, differentiate, and repopulate the conducting
airway epithelium. Previous studies that directly test whether
repeated depletion of Clara cells exhaust bronchiolar stem cell
pools were limited by insufficient long-term survival after
chronic Clara cell depletion (2, 6).
In sharp contrast to rapid repair after acute lung injury,
chronic injury results in structural remodeling of lung tissue,
commonly associated with chronic lung diseases, including
asthma, chronic bronchitis, chronic obstructive pulmonary
disease (COPD), and bronchiolitis obliterans syndrome
(BOS) (9–12). A better understanding of the cellular and
molecular processes mediating bronchiolar regeneration, as
well as the pathogenesis of fibrosis after loss of epithelial
integrity, is needed to develop effective therapeutic strategies
for chronic pulmonary disorders. Histological evaluation of
human biopsies support the concept that pulmonary fibrosis is
caused by failure of epithelial repair due to ineffective pro-
liferation, migration, and differentiation (13); these findings
are supported by animal models that demonstrate the impor-
tance of airway homeostasis and the role of epithelial cell
injury in the pathogenesis of pulmonary fibrosis (14–16). It
remains unclear whether transdifferentiation of alveolar type
II cells to mesenchymal cells (epithelial–mesenchymal transi-
tion, EMT) or migration of nonpulmonary cells into the lung
plays an important role in the progression of pulmonary
fibrosis (14, 15, 17).
Although many studies have suggested that injury of the
alveolar epithelium causes pulmonary fibrosis, studies regarding
the pathogenesis of bronchiolar fibrosis are limited. The present
study was designed to develop a mouse model to conditionally
deplete Clara cells to study bronchiolar regeneration after acute
and chronic injury, and to test whether chronic Clara cell death
results in ineffective repair, progenitor cell exhaustion, and
fibrosis. We used the rat Scgb1a1 (secretoglobin, family 1A,
member 1) promoter to conditionally express a diphtheria toxin
A gene (DT-A) causing cell autonomous death. Administration
of doxycycline (dox) activates Cre recombinase in Clara cells,
and initiates genomic recombination of an otherwise silent
DT-A gene to cause cell death. Continuous Clara cell depletion
caused peribronchiolar fibrosis and regional exhaustion of pro-
AT A GLANCE COMMENTARY
Scientific Knowledge on the Subject
Nonciliated bronchiolar epithelial cells participate in the
repair of the airway after acute injury. In humans, successive
lung injury and failure to repair the respiratory epithelium
are associated with fibrosis as seen in idiopathic pulmonary
fibrosis, bronchiolitis obliterans, and other lung diseases, and
suggest that the epithelial cells fail to repair the damaged
epithelium because of ineffective proliferation, migration,
and differentiation.
What This Study Adds to the Field
We provide evidence that repeated injury to nonciliated
bronchiolar epithelial cells is sufficient to cause pulmonary
fibrosis at sites of insufficient repair and reepithelialization.
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genitor cells. Portions of these results have been presented
previously in abstract form (18).
METHODS
Additional detail on the methods is provided in the online supplement.
Transgenic Mice and Tissue Harvest
To achieve both Clara cell–specific and time-controlled expression of
DT-A a triple transgenic mouse model was generated using the reverse
tetracycline activator (rtTA), Cre recombinase, and a loxP-activated
DT-A gene (5, 19–22). Dox was given to mice via their food (dox,
625 mg/kg chow; Harlan Teklad, Madison, WI) (23). Triple transgenic
Scgb1a1rtTA/tetOCre/R26:lacZ/DT-A mice (termed Scgb1a1/DT-A
hereafter) were used in all studies. Wild-type, single transgenic litter-
mates and untreated triple transgenic mice served as controls. In the
present study, two independent Scgb1a1rtTA founder lines (line 1
and line 2) were compared for their ability to target Cre and subsequent
DT-A expression to Clara cells in the bronchiolar epithelium. Because
Clara cell depletion was more extensive in Scgb1a1/DT-A mice of
line 2, this line was used for subsequent acute and chronic injury studies.
For acute lung injury studies, mice were treated with dox for 2 days.
Chronic lung injury was induced by continued dox treatment for 10 days.
Three to five animals per group were analyzed. Mice were killed by
injection of 0.2–0.3 ml of anesthetic containing ketamine, xylazine, and
acepromazine. Lungs were inflation-fixed with 4% paraformaldehyde,
fixed overnight at 48C, and processed for paraffin embedding. Peroxidase
and fluorescence immunohistochemistry was performed on paraffin
sections as previously described (24).
Mitotic Index and Proliferation in Neuroepithelial Bodies and
Bronchiolar Alveolar Duct Junction Regions
The mitotic index was assessed by fluorescence immunohistochemistry
for phosphohistone H3–positive cells or Ki67-positive nuclei. Six sec-
tions (spaced 80–100 mm apart) containing all five lobes, from three to
five mice per group and time point, were double-labeled for Ki67 and
calcitonin gene–related peptide (CGRP) and counterstained with 49,6-
diamidino-2-phenylindole (DAPI). Per slide, five to seven random,
nonoverlapping pictures (magnification, 310) containing bronchiolar
airways were photographed and analyzed with MetaMorph software
(Molecular Devices, Sunnyvale, CA). Neuroepithelial body (NEB)
regions were determined by positive CGRP staining. The number of
positive cells per millimeter of airway and the percentage of positive
cells per DAPI-positive cell in NEB and non-NEB regions were
determined. Three sections of three to five animals per group and
time point, containing all five lobes, were triple labeled for Ki67, pro–
surfactant protein C (SPC), and Clara cell secretory protein (CCSP)
and counterstained with DAPI. A minimum of 15 BADJ regions per
animal were examined for colocalization of CCSP, pro-SPC, and Ki67.
Quantitative Analysis
Morphometric analysis for Clara cell depletion, extent of fibrosis, and
extent of epithelial denudation was performed on random sections
containing all five lobes of two or three mice per group. Nonoverlapping
pictures of all airways on these slides were photographed and analyzed
with MetaMorph software (Molecular Devices). The length of total
airway epithelia and of CCSP-positive and pan-cytokeratin–positive
airway epithelia was determined (goat anti-CCSP, diluted 1:5,000 [Santa
Cruz Biotechnology, Santa Cruz, CA] and mouse anti–pan-cytokeratin,
diluted 1:500 [Sigma, St. Louis, MO]). The area of mesenchymal tissue
adjacent to the bronchiolar basement membrane was determined. Clara
cell depletion was expressed as the percentage of airways covered with
CCSP-positive cells. Extent of fibrosis was determined as area per
millimeter of airway. Extent of epithelial denudation was expressed as
the percentage of airway lacking pan-cytokeratin–positive staining, using
light microscopy at 340 magnification.
RESULTS
Conditional Expression of Diphtheria Toxin in Clara Cells
Cre-mediated activation of DT-A has been successfully used in
other organs to deplete endocardial cells, dendritic cells, in-
testinal stem cells, cardiovascular smooth muscle cells, oligoden-
drocytes, B cells, and hepatocytes (25–29). This mouse model
differs from prior studies in that Cre-mediated recombination
was activated by the reverse tetracycline activator after dox
treatment, enabling temporal and cell type–specific control of
the DT-A expression in a subset of epithelial cells in the lung.
We used two independent Scgb1a1rtTA mouse lines, line 1 (19)
and line 2 (30), that vary in the extent to which Clara cells express
Cre recombinase. Both lines were generated with a 2.3-kb rat
Scgb1a1 gene promoter. Cre expression in the bronchiolar
epithelium was detected in both mouse lines, but was more
widespread in line 2 (see Figure E1 in the online supple-
ment). Transgenic Scgb1a1rtTA/tetOCre mice of lines 1 and 2
were mated to R26:lacZ/DT-A transgenic mice (21). In the triple
transgenic progeny, Scgb1a1/DT-A, Cre recombination was acti-
vated by dox for 2 or 10 days to induce activation of DT-A causing
acute or chronic Clara cell ablation, respectively (Figure E2).
Acute Clara Cell Depletion after 2 Days of DT-A Activation
To determine the timing and extent of Clara cell depletion after
DT-A expression, morphological changes in the bronchiolar
epithelium were assessed 2 days after exposure to dox and 2
days after withdrawal from dox (Figure 1). Histological changes
in the bronchiolar epithelium were not detected after 2 days of
dox treatment, but were readily detected 2 days after with-
drawal from dox. Insufficient Clara cell targeting and ablation
of a subset of Clara cells in line 1 resulted in Clara cell hyper-
plasia (Figure 1C). Increased proliferation in nontargeted Clara
cells was confirmed by increased expression of phosphohistone
H3 (inset in Figure 1B). Rapid cell replacement was seen in
diphtheria toxin receptor–expressing dendritic cells but not in
podocytes of the kidney (31, 32). This Clara cell hyperplasia
suggests that ‘‘nontargeted’’ Clara cells or other progenitor cells
respond to epithelial injury with rapid proliferation. A similar
increase in cell proliferation has been shown in a different DT-A
mouse model, in which the human diphtheria toxin receptor is
expressed in alveolar type II cells (16). In contrast, in line 2, the
majority of Clara cells in the lung bronchioles were ablated
during dox treatment, leaving a squamous epithelium with rare
clusters of cuboidal cells. Using two CCSP antibodies that differ
in their sensitivity to detect CCSP protein, we determined that
4.5 6 2.0% of the remaining cells expressed low levels of CCSP
and were likely untargeted Clara cells or cells that were newly
derived from bronchiolar progenitor cells after dox withdrawal
(Figure 1F). Subsequent studies, to determine repair after acute
and chronic Clara cell ablation, were performed in triple
transgenic mice using Scgb1a1rtTA line 2.
Regeneration of Bronchiolar Cells after Acute Clara
Cell Death
Hematoxylin and eosin staining and CCSP immunohistochem-
istry were used to assess histological changes after exposure of
Scgb1a1/DT-A mice to 2 days of dox treatment and either 2,
5, or 10 days of subsequent repair (Figures 2A22H). Most
bronchiolar epithelial cells were still present in the bronchiolar
epithelium 2 days after dox exposure (Figures 2A and 2E); this
delay in cell death is likely due to dox pharmacodynamics, and
the lag time between dox uptake, rtTA and Cre protein
expression, DNA recombination, and activation of DT-A pro-
tein expression. However, during the subsequent 2 days more
than 95.5 6 2.0% of Clara cells were lost, leaving a squamous
bronchiolar epithelium (Figures 2B and 2F). CCSP protein
expression in these cells could be detected only with the more
sensitive antibody to CCSP (Figure 2F), suggesting that all these
Clara cells expressed low levels of CCSP protein. The percent-
age of Clara cells increased gradually after 5 days (Figures 2C
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and 2G). After 10 days, regenerating cells had formed larger
clusters of Clara cells that stained intensively for CCSP and
covered 45.5 6 16.2% of the airways (Figure 2H). To determine
whether remaining ciliated cells covered the basement membrane,
we performed immunohistochemistry for b-tubulin (Figures
2I22L). Despite extensive depletion of Clara cells, bronchiolar
epithelial integrity was maintained as b-tubulin IV–expressing
ciliated cells formed a squamous monolayer (Figures 2I22L).
These findings are consistent with previous observations after
naphthalene-induced Clara cell injury (6, 33, 34).
Proliferation of Clara Cells But Not Ciliated Cells during
Bronchiolar Regeneration
To determine the cell types contributing to regenerating cells in
the bronchiolar epithelium, we colocalized the proliferation
marker Ki67 with CCSP or FOXJ1 (forkhead-box J1) expres-
sion. To detect low levels of CCSP expression we used the more
sensitive goat anti-CCSP antibody in all immunofluorescence
studies (Figure 3). Although generally nonproliferative, 8.5 6
4.4% of the bronchiolar cells proliferated after 2 days, and 10.06
7.7% proliferated after 5 days. Whereas a subset of proliferative
cells expressed low levels of CCSP, a distinct subset of pro-
liferative cells were cuboidal and lacked both CCSP and FOXJ1
expression (Figure 3D). Five days after withdrawal from dox, all
Ki67-positive cells were CCSP positive and FOXJ1 never colo-
calized with Ki67 (Figures 3B, 3E, and 3H). FOXJ1 colocalized
with CCSP in a subset of cells after 5 days of recovery, perhaps
indicating differentiation of a subset of Clara cells into ciliated
cells (Figure 3I).
Proliferation in Selected Cell Niches in the Bronchioles
Epithelial regeneration after naphthalene injury has been
associated with a subpopulation of naphthalene-resistant Clara
cells (variant Clara cells) that are located at selective stem cell
Figure 1. Clara cell depletion after acute
doxycycline (dox) exposure: Hematoxylin
and eosin staining of histological lung
sections after (A and D) 2 days of dox
exposure and (B and E ) 2 days of dox
exposure followed by 2 days of recovery
in triple transgenic mice from (A–C )
Scgb1a1rtTA line1and (D–F ) Scgb1a1rtTA
line 2. Immunohistochemistry for the pro-
liferation marker phosphohistone H3
(pH3) revealed increased proliferation in
Scgb1a1rtTA line 1 (inset in B ); (C and F )
immunohistochemistry using goat anti–
Clara cell secretory protein (CCSP)
revealed that 95.5 6 2.0% of Clara cells
were depleted after 2 days of dox expo-
sure and 2 days of recovery. Arrows in B
and C indicate bronchiolar hyperprolifer-
ation; arrows in E and F indicate clusters
of cuboidal cells; asterisks in E show cells sloughing off; the arrowhead in F shows a bronchiole depleted of Clara cells. Figures are representative of at
least five individual mice per genotype and at each time. Scale bars: (A, B, D, and E ) 20 mm; (C and F ) 500 mm.
Figure 2. Residual squamous cells main-
tain the bronchiolar epithelium. (A, E,
and I ) Triple transgenic mice were ex-
posed to doxycycline (dox) for 2 days to
activate diphtheria toxin A (DT-A) by Cre
recombination. Histology was assessed
(B, F, and J ) 2 days, (C, G, and K) 5 days,
and (D, H, and L) 10 days after dox
withdrawal, using (A–D) hematoxylin
and eosin (H&E) staining. (E–H) Rabbit
anti–Clara cell secretory protein (CCSP),
(F ) a more sensitive goat anti-CCSP (in-
set), and (I–L) b-tubulin antibodies were
used to stain the tissue. After 2 days of
dox, residual cuboidal cells in the bron-
chioles express high levels of CCSP (E,
arrowhead ). Two days after dox with-
drawal only 4.5 6 2% of cells express
CCSP; expression in these cells is low and
can be detected only with the more
sensitive goat anti-CCSP antibody. Be-
tween 5 and 10 days after dox with-
drawal, the percentage of CCSP-positive
cells increased to 45.5 6 16.2% and the
level of CCSP expression per cell increased (G and H, arrowheads). In the absence of cuboidal cells, squamous ciliated cells (arrowheads in I–L)
covered the bronchioles. Results are representative of n > 3 triple transgenic Scgb1a1/DT-A mice.
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niches near neuroepithelial bodies (NEBs) (6, 35). NEBs are
small clusters of cells that express calcitonin gene–related
peptide (CGRP) and other neuropeptides. To assess whether
proliferation capacity was selectively increased in NEB-related
sites, dual immunohistochemistry for CCSP and CGRP was
performed on lungs after 2 and 5 days of recovery. Regenerat-
ing CCSP-positive cells were found in both NEB-associated and
non-NEB–associated regions, with many NEB regions being
denuded of regenerating CCSP-staining cells (Figures 4A and
4B). Morphometric analysis indicated that cell density in NEB
regions was significantly increased after 2 and 5 days of recovery
(Figure 4C). To assess proliferation of Clara cell progenitor
cells in NEB regions, we performed dual immunohistochemistry
for CGRP and Ki67. The proliferation index in bronchiolar
regions with and without positive CGRP staining was deter-
mined as a percentage of Ki67-positive cells per nucleus of
bronchiolar cells (Figure 4D). Morphometric analysis indicated
that the proliferation index in both NEB-associated and non-
NEB–associated regions of the bronchioles was comparable
after 2 days of recovery and slightly elevated after 5 days of
recovery (Figure 4D). Proliferation was increased in regions
with higher cell density and was correlated with the presence of
CCSP-positive cells. These data suggest that proliferating cells
are widely distributed throughout the airways after 2 days of
recovery and are associated with areas of high cell density after
5 days of recovery.
A second potential niche of airway stem cells has been
identified in the bronchiolar alveolar duct junction (BADJ)
region, where rare cells express both CCSP and the alveolar
type II cell marker, pro–surfactant protein C (pro-SPC) (36). To
assess the presence of these dual-positive cells colocalization of
CCSP and pro-SPC was performed by immunohistochemistry
during DT-A activation and bronchiolar recovery (Figures
4E24H). Rare CCSP- and pro-SPC–positive cells were found
only after 2 days of recovery; these cells expressed low levels of
CCSP (Figure 4F). Colocalization studies with CCSP, pro-SPC,
and Ki67 were assessed during repair. No colocalization of all
three markers, CCSP, pro-SPC, and Ki67, was detected, sug-
gesting that CCSP/pro-SPC dual-positive cells within BADJ
regions were not proliferative and perhaps represent an in-
termediate state of bronchiolar and alveolar cell differentiation.
Exhaustion of Clara Cell Progenitors
After acute Clara cell depletion, the majority of proliferative
cells stained for CCSP and had repopulated 45.56 16.3% of the
bronchiolar epithelium within 10 days. However, although
significantly more Clara cells were present after 3 weeks of
recovery (70.6 6 4.7%; P , 0.001), 29.4% of the bronchiolar
regions still lacked CCSP-expressing cells (arrowheads in Fig-
ures 5B and 5C; Figure 6), suggesting an important role for
Clara cells in the regeneration of bronchiolar epithelium. To
establish a chronic injury model and to deplete existing and
newly forming Clara cells, Scgb1a1/DT-A mice were treated
with dox for 10 days. The extent of Clara cell depletion and
repair was assessed by immunohistochemistry for CCSP after
10 days and 3 weeks (Figures 5D25F and Figure 6A). After
10 days of dox-induced DT-A expression, the bronchiolar epi-
thelium consisted of a thin squamous epithelial cell layer and
16.56 8.6% of cuboidal cells that expressed low levels of CCSP.
After 10 days of repair Clara cells had significantly repopulated
bronchioles (65.7 6 11.6%; P , 0.001), and thereafter the
percentage of Clara cells remained the same (57.7 6 6.9%; P ,
0.2) (arrows in Figures 5E and 5F; Figure 6A). Large areas of
squamous epithelial metaplasia persisted (arrowheads in Fig-
ures 5E and 5F). To determine whether prolonged depletion of
Clara cells resulted in regional exhaustion of Clara cell pro-
genitors and abnormal epithelial repair, lung histology was as-
sessed 19 weeks after withdrawal from dox (Figures 5G25I).
Although Clara cells covered most bronchioles, extensive epi-
thelial metaplasia persisted (arrowhead in Figure 5G), supporting
the concept that continuous depletion of Clara cells and newly
differentiating Clara cells had exhausted resident progenitor cell
pools. Aberrant bronchiolar repair was evident, as clusters of
Clara cells were observed inside the bronchiolar lumen (Figures
5H and 5I), thus demonstrating that continuous depletion of
Clara cells triggers regional hyperproliferation of Clara cells that
form aberrant epithelial clusters while other regions remain
denuded of Clara cells.
Figure 3. Cell proliferation during repair of the
bronchiolar epithelium. Mice were treated with
doxycycline (dox) for 2 days; proliferation was
assessed after 2 days of dox treatment and 2 and
5 days of recovery, using immunohistochemis-
try for the proliferation marker Ki67. After 2 days
of recovery 8.5 6 4.4% of the cells were pro-
liferative and 10.0 6 7.7% were proliferative
after 5 days. Immunofluorescence images were
merged with images acquired using differential
interference contrast optics: goat anti–Clara cell
secretory protein (CCSP) (green in A, D, and G;
red in C, F, and I ), Ki67 (pink), forkhead-box J1
(FOXJ1; green). Ki67 expression was colocalized
with CCSP in Clara cells but not with FOXJ1
staining (ciliated cells). Colocalization of CCSP
and FOXJ1 showed a subset of dual-positive cells
at 5 days but not at 2 days of recovery. Arrows,
double-positive cells; asterisk, rare proliferating
cuboidal cell that lacks CCSP. Results are repre-
sentative of n > 3 triple transgenic Scgb1a1/
DT-A mice.
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Airway Wall Fibrosis after Chronic Clara Cell Depletion
Acute and chronic graft rejection after lung transplantation or
bone marrow transplantation causes inflammation and bronchi-
olar fibrosis, known as bronchiolitis obliterans syndrome (9). To
assess the potential effect of chronic Clara cell depletion on the
induction of bronchiolar fibrosis, mice were treated with dox for
10 days. Continuous depletion of Clara cells for 10 days caused
thickening of the peribronchiolar stroma at sites associated with
squamous epithelial metaplasia. Morphometric analysis deter-
mined that the average thickness of the mesenchyme adjacent
to the basement membrane increased significantly from 4.8 6
0.3 to 12.6 mm2/mm of airway (P , 0.001) (Figure 6B) after
chronic injury. Peribronchiolar fibrosis persisted throughout 10-
and 21-day recovery periods with thickening of 14.1 6 0.2 and
14.4 6 0.1 mm2/mm, respectively (P , 0.14) (arrowheads in
Figures 5D25F; Figure 6B). After 19 weeks of recovery, peri-
bronchiolar fibrosis was associated with bronchioles in which
Clara cells had regenerated (arrows in Figures 5G and 5H),
demonstrating that peribronchiolar fibrosis was nonreversible in
spite of substantial epithelial regeneration.
To further characterize the peribronchiolar fibrosis and
fibrotic lesions, immunohistochemistry was performed with
markers for specific cell types and for cell proliferation (Figures
7A27D). Trichrome staining was used to assess extracellular
matrix deposition (Figure 7E). After 10 days of dox treatment,
followed by either 2 or 10 days of recovery, the peribronchiolar
thickening was most prominent at sites of squamous epithelium
that lacked both Clara and ciliated cells (Figures 7A and 7B).
Fibrotic regions contained proliferating fibroblasts, capillaries,
extracellular matrix, and collagen (Figures 7C27E), thus re-
sembling fibromyxoid plugs of granulation tissue. Because an
increase in myofibroblast activity has been found in animal
models of pulmonary fibrosis (37, 38), we performed immuno-
histochemistry for a-smooth muscle actin (a2SMA). The
smooth muscle layer was not increased in these fibrotic areas
(Figure 7F). These data support the concept that peribronchio-
lar fibrosis was associated with proliferating fibroblasts and
deposition of extracellular matrix but was not associated with
peribronchiolar smooth muscle hyperplasia, suggesting that
fibrosis was independent of myofibroblast proliferation or
differentiation.
Investigation of EMT
In many adult tissues, epithelial cells respond to stress or injury
by a dedifferentiation process termed the epithelial–mesenchy-
mal transition (EMT) (17). To evaluate whether EMT contrib-
uted to the peribronchiolar fibrosis after chronic Clara cell
ablation we assessed immunohistological markers associated
with EMT (39). After 10 days of dox treatment, areas with
moderate peribronchiolar fibrosis (Figure 8) and intrabronchio-
lar fibrotic lesions were compared (Figure 9). Regions with
Figure 4. Assessment of proliferation in neuroepithelial body (NEB)
and bronchiolar alveolar duct junction (BADJ) regions. Immunohisto-
chemistry was performed for Clara cell secretory protein (CCSP) (green
in A, red in E–H ), calcitonin gene–related peptide (CGRP) (red in A,
green in B), Ki67 (red in B ), and pro–surfactant protein C (SPC) (green
in E–H ). (A and B) NEB regions were determined by positive CGRP
staining and included bronchiolar cells covering the NEB and two or
three cells outside the CGRP-positive area. After 2 days of doxycycline
(dox) treatment and 5 days of recovery, not all NEB regions were
covered with regenerating Clara cells; proliferating cells were found
outside of NEB regions. (C and D) Sections containing all five lobes
were double labeled for Ki67 and CGRP, and counterstained with 49,6-
diamidino-2-phenylindole (DAPI). The number of DAPI-positive cells
per millimeter of airway and the percentage of KI67-positive cells per
DAPI-positive cell in NEB and non-NEB regions were determined. (C )
Cell density around NEB regions (solid columns) was 112 cells/mm of
airway after 2 days of recovery and 143 cells/mm after 5 days of
recovery, which was significantly more than the 66 and 81 cells/mm in
the non-NEB regions (open columns) (P , 0.018 and P , 0.045,
respectively). (D) After 2 days of recovery proliferation in NEB (solid
columns; 9.5%) and non-NEB (open columns; 8.5%) regions was
comparable (P , 0.155). After 5 days of recovery proliferation in
NEB (black; 14.7%) was slightly increased when compared with non-
NEB regions (white; 10.0%) (P , 0.029). Results are expressed as the
means 6 SE of six sections of three to five animals per group. (E–H )
Colocalization of goat anti-CCSP (red ) and SPC (green) in the
bronchiolar epithelium was assessed after acute injury and recovery
for 2, 5, and 10 days. Immunofluorescence images were merged with
images acquired with differential interference contrast optics. Only
after 2 days of recovery were rare clusters of dual-positive cells found in
BADJ regions (1 cluster per 15 BADJ regions). High magnification of
a dual-positive BADJ cluster is shown in the inset in (F ). Results are
representative of more than 45 BADJ regions from 3 sections, contain-
ing all 5 lobes, of 3–5 triple transgenic Scgb1a1/DT-A animals per
group at each time point.
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moderate airway wall thickening were covered by a thin,
squamous epithelium that stained for pan-cytokeratin and
lacked N-cadherin (Figures 8A and 8B). Fibrotic lesions
growing into the bronchiolar space were associated with regions
that lacked epithelial cells, as indicated by the absence of pan-
cytokeratin (Figure 9A). Morphometric analysis revealed that
after acute injury 0.5–2.5% of bronchiolar epithelium was
denuded whereas 6–28% was denuded after chronic injury. N-
cadherin expression, normally absent in bronchioles, was in-
duced in epithelial cells adjacent to the intrabronchiolar lesions
(Figure 9B), suggesting a more migratory phenotype for these
epithelial cells (40). Collagen IV staining was detected in
regions with moderate peribronchiolar fibrosis but was not seen
throughout the intrabronchiolar fibrotic lesions (Figures 8 and
9C). Staining for desmin, drebrin (data not shown), a-SMA,
and vimentin (Figure 8 and Figures 9D29F) revealed that both
airway wall thickening and intrabronchiolar lesions occurred in
the absence of fibroblast-to-myofibroblast differentiation. Ex-
pression of the epithelial transcription factor TTF-1 (thyroid
transcription factor-1) was weak and patchy, suggesting loss of
differentiation or absence of epithelial cells (Figure 8 and
Figures 9E and 9F). These data suggest that epithelial cells
associated with peribronchiolar fibrosis (Figure 8) undergo
partial dedifferentiation associated with loss of markers for
differentiated epithelial cells (CCSP, TTF-1, b-tubulin) but
maintain expression of pan-cytokeratin, indicating their epi-
thelial phenotype. Complete loss of epithelial cells, as demon-
strated by lack of pan-cytokeratin and N-cadherin expression,
was associated with fibrotic callus formation in the airway
lumen. These lesions stained positive for vimentin and plate-
let–endothelial cell adhesion molecule (PECAM) but lacked
a-SMA, suggesting granulation tissue formation after loss of the
bronchiolar epithelium. Staining for SNAIL, SLUG, and
TWIST, transcription factors associated with EMT, was not
detected in regions of peribronchiolar fibrosis or intrabronchio-
lar lesions during acute or chronic injury or during recovery
periods (Figure 10).
DISCUSSION
In this study, we have shown that Clara cells are critical airway
progenitor cells and that chronic Clara cell depletion resulted in
exhaustion of bronchiolar progenitor cell pools and peribron-
chiolar fibrosis (Figure 11). Evidence that the Clara cells are an
important progenitor cell population has been demonstrated in
two ways. First, proliferation during epithelial repair was associ-
ated primarily with Clara cells that expressed low levels of CCSP
and was not found in ciliated cells or in dual-positive CCSP- and
pro-SPC–expressing cells in the BADJ regions. In our system
proliferating cells were widely distributed along the airways and
were not selectively associated with NEBs or the BADJ regions.
Increased proliferation of Clara cells in the hyperplastic regions,
which was seen after DT-A–mediated Clara cell depletion in line
1, supports the concept that Clara cells are important progenitor
cells of the bronchiolar epithelium (2, 6, 7, 35).
Second, we found that continuous depletion of Clara cells
resulted in ineffective epithelial repair, resulting in chronic
squamous epithelial metaplasia and peribronchiolar fibrosis.
Peribronchiolar fibrosis was associated with increased prolifer-
ation of fibroblasts, reduced expression of the epithelial marker
TTF-1, and induction of N-cadherin and vimentin. At the time
points analyzed and with the methods used, we could not detect
expression of EMT-related transcription factors (SNAIL,
SLUG, TWIST) or colocalize epithelial and mesenchymal
markers. Detection of these EMT markers might have been
limited by the sensitivity of the antibodies and the short time
frame during which these proteins are expressed. Moreover,
EMT is a transient process and colocalization of epithelial and
mesenchymal markers in the same cells is rare and difficult to
demonstrate. Therefore the origin of the fibroblasts in these
lesions remains unclear at present. Focal loss of epithelial
integrity was associated with lack of pan-cytokeratin expression,
intrabronchiolar lesions, and increased proliferation of subepi-
thelial fibroblasts. These data support the concept that loss of
epithelial integrity and fibroblast proliferation cause the fibrotic
Figure 5. Chronic loss and aberrant re-
pair of Clara cells after continuous diph-
theria toxin A (DT-A) expression.
Immunohistochemistry for Clara cell se-
cretory protein (CCSP) was assessed on
lung sections of triple transgenic
Scgb1a1/DT-A mice after 2 days (A–C)
or 10 days of DT-A expression (D–I), and
recovery for (B and E) 10 days, (C and F)
3 weeks, and (G–I) 19 weeks. After 3
weeks of recovery Clara cells lined many
bronchioles (arrows) but were absent in
some bronchiolar regions. After 19
weeks of recovery, some bronchioles still
lacked Clara cells (arrowheads in B–G).
Peribronchiolar fibrosis was found after
10 days of doxycycline (dox) treatment
(insets in D and E) and persisted through-
out 19 weeks of recovery (arrows in H).
After 19 weeks of recovery, aberrant
epithelial repair was evident (H). Scale
bars: (A–F ) 200 mm; (G and H) 100 mm;
(I) 5 mm. Results are representative of
n > 3 triple transgenic Scgb1a1/DT-A
mice.
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process, associated with chronic DT-A–mediated Clara cell
depletion.
Clara Cell Progenitors Are Not Selectively Associated with
BADJ Regions or NEBs
Nonciliated bronchiolar epithelial cells are thought to repair the
bronchiolar epithelium after injury (2–4), as previously reported
in lineage-tracing studies (7, 41, 42) and studies inactivating
Sox2, a transcription factor associated with stem cell behavior
(8, 43), supporting the concept that basal cells and Clara cells
serve as progenitor cells for tracheal, bronchial, and bronchiolar
epithelium. However, in the mouse basal cells are not found in
the bronchioles (44). NO2 and ozone selectively kill ciliated
cells that are regenerated by Clara cells (45, 46). Acute Clara
cell depletion after naphthalene treatment has a well-defined
pattern of repair (1, 3, 6, 35, 47–50). Clara cells express cyto-
chrome P450, which metabolizes naphthalene to a toxic in-
termediate causing cell autonomous death (49, 50). It remains
unclear whether all Clara cells or only restricted subpopulations
of naphthalene-resistant Clara cells have the capacity to self-
renew, differentiate, and repopulate the conducting airway (35,
36, 51). After naphthalene injury, surviving progenitor cells are
enriched in selected niches associated with tracheal–bronchial
glands, BADJ regions, and NEBs (6, 35, 36, 51, 52). Clara cells
located at the BADJ have been identified by coexpression of
CCSP and pro-SPC and have therefore been proposed to serve
as bronchiolar–alveolar stem cells (36). In the present study
CCSP- and pro-SPC–expressing cells in BADJ regions did not
proliferate, and the number of proliferating cuboidal cells in the
NEB regions was not increased. Our results suggest that
regenerating cells are not selectively associated with NEB and
BADJ regions and support studies demonstrating that regener-
ating cells are randomly distributed throughout the airways and
contribute to airway homeostasis after moderate naphthalene
injury (51). The same studies, however, showed that regenera-
Figure 6. Extent of Clara cell depletion and mesenchymal fibrosis.
Random sections from two or three animals and containing all five
lobes were stained for Clara cell secretory protein (CCSP). Pictures of all
airways were taken. (A) The length of total airways and CCSP-positive
airways was determined. Clara cell depletion was expressed as the
percentage of airways covered with CCSP-positive cells. In airways with
no injury CCSP stain covered 100% of the airways. After 2 days of
doxycycline (dox) and 2 days off dox treatment only 4.5 6 2.0% of the
airways were covered with Clara cells. After 10 days Clara cells
significantly regenerated to cover 45.5 6 16.3% of the bronchioles
(P , 0.001) and continued to significantly regenerate to cover 70.6 6
4.7% after 21 days of recovery (P, 0.001). After 10 days of dox 16.56
8.6% of the airways were CCSP positive, which is comparable to
denudation after 2 days (P , 0.06). Ten days after chronic injury Clara
cells regenerated and covered 65.7 6 11.6% (P , 0.001) of the
airways. Thereafter the percentage of Clara cells did not increase
(57.7 6 6.9%; P , 0.20). (B) The area of mesenchymal tissue adjacent
to the bronchiolar basement membrane was determined in uninjured
bronchioles and after 10 days of dox exposure. The extent of fibrosis
was determined as millimeters squared per millimeter of airway. In
uninjured animals the average size of the underlying mesenchyme was
4.8 6 0.3 mm2/mm of airway. After 10 days of injury the mesenchyme
increased in thickness to 12.6 6 2.0 mm2/mm (P , 0.001) and
remained at 14.1 6 0.2 and 14.4 6 0.1 mm2/mm after 10 and 21
days of repair (P , 0.39). Results are expressed as means 6 SE of 80–
160 mm of airway from two or three animals per group.
Figure 7. Chronic Clara cell depletion results in peribronchiolar
fibrosis. After 10 days of doxycycline (dox) treatment, immunohisto-
chemistry on lung sections of triple transgenic mice for cell type–
specific markers was performed with (A) goat anti–Clara cell secretory
protein (CCSP), (B ) b-tubulin, (D) platelet–endothelial cell adhesion
molecule (PECAM), and (F ) a-smooth muscle actin (a-SMA). Pro-
liferation was assessed by (C ) Ki67 staining and extracellular matrix
deposition was assessed by (E) trichrome staining. Peribronchiolar
fibrosis was associated with loss of Clara cells, proliferating fibroblasts,
and deposition of extracellular matrix but was not associated with
smooth muscle hyperplasia. Results are representative of n > 3 triple
transgenic Scgb1a1/DT-A mice.
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tion after severe naphthalene injury occurred in rare cell patches
that were associated with proposed stem cell niches (35, 51).
Discrepancies between the association of progenitor cells
with NEBs and BADJ regions and the random distribution of
progenitor cells throughout the bronchiolar epithelium may be
due to differences in how Clara cells were ablated. In the
present study, Clara cells were depleted by dox-mediated DT-A
activation, which depended on Scgb1a1 promoter activity. In
contrast, naphthalene injury depends on the expression of the
cytochrome P450 protein, which is normally found in mature
Clara cells (6). NEBs and BADJ regions harbor naphthalene-
resistant variant Clara cells that express low levels of P450.
Although low levels of P450 protect these cells from naphtha-
lene injury, these cells can be ablated by the transgenic
approach with the Scgb1a1 promoter. Randomly distributed
Clara cells and Clara cell progenitors that are not ablated by
Scgb1a1 promoter-dependent DT-A expression might have high
levels of P450 protein expression, which allows ablation by
naphthalene. Differences in the extent and type of cells targeted
by conditional DT-A or naphthalene injury may account for
regional differences in Clara cell depletion and subsequent
regeneration in these models.
In the present study, we demonstrate that continuous de-
pletion of newly formed Clara cells impaired regeneration of
the bronchiolar epithelium and resulted in persistent squamous
epithelial metaplasia and lack of Clara cell regeneration (Figure
11). These data suggest a critical role for Clara cells as pro-
genitors of regenerating bronchiolar epithelial cells, although the
progenitor of variant Clara cells and randomly dispersed Clara
cell progenitors remains unclear. Although lineage-tracing
studies would be useful to identify these progenitor cells, cell-
specific labeling using Cre recombinase also activates DT-A in
the DT-A transgenic model, and therefore results in cell death.
We observed low levels of CCSP protein expression at the
beginning of bronchiolar repair, indicating that this subset of
Clara cells is likely derived from progenitor cells that do not
have Scgb1a1 promoter activity during dox exposure and thus
do not activate DT-A. The finding that repairing regions
express high levels of CCSP and could be ablated by continuous
dox treatment supports this hypothesis.
Ineffective Epithelial Repair Causes Fibrosis
BOS is associated with focal denudation of the basement
membrane and loss of epithelial integrity (9, 10). In the present
model chronic depletion of Clara cells caused focal denudation
of the basement membrane, peribronchiolar fibrosis, and re-
gional formation of intrabronchiolar fibrotic lesions that re-
semble early stages of the fibromyxoid plugs found in patients
with BOS. Our data support the concept that chronic epithelial
loss results in ineffective epithelial repair and fibrosis by
Figure 8. Immunohistochemistry (IHC) for epithelial and stromal cell
markers in regions of peribronchiolar fibrosis. IHC was performed for
(A) pan-cytokeratin, (B ) N-cadherin, (C ) collagen IV, and (D) desmin,
and dual immunofluorescence was performed for thyroid transcription
factor (TTF)-1 and the smooth muscle cell marker a-smooth muscle
actin (a-SMA) (E) or the mesenchymal marker vimentin (F ). A squa-
mous layer of pan-cytokeratin–positive epithelial cells lined the bron-
chioles. Weak and patchy expression of TTF-1 suggested loss of
epithelial differentiation; lack of desmin and a-SMA expression dem-
onstrated that fibrosis was not due to myofibroblast hypertrophy.
Arrows, TTF-1 expression in alveolar type II cells; arrowheads, low
TTF-1 expression in squamous cells. Results are representative of n >
3 triple transgenic Scgb1a1/DT-A mice.
Figure 9. Immunohistochemistry for epithelial and stromal markers in
regions of fibromyxoid plugs. Immunohistochemistry was performed
for (A) pan-cytokeratin, (B ) N-cadherin, (C ) collagen IV, and (D)
desmin, and dual immunofluorescence was performed for thyroid
transcription factor (TTF)-1 and the smooth muscle cell marker
a-smooth muscle actin (a-SMA) (E ) or the mesenchymal marker
vimentin (F ). The epithelial layer was interrupted in regions of fibrotic
callus formation, and fibrotic lesions contained vimentin-positive,
a-SMA–negative fibroblasts. Arrows, TTF-1 expression in alveolar type
II cells; arrowhead, low TTF-1 expression in squamous cells. Results are
representative of n > 3 triple transgenic Scgb1a1/DT-A mice.
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inducing proliferation of fibroblasts and deposition of collagen.
This concept is supported by lung biopsies from patients with
idiopathic pulmonary fibrosis, in which cell hyperplasia, apo-
ptosis, and chronic denudation of epithelial cells from the
basement membranes were detected (53–55). Furthermore,
alveolar fibrosis was induced in studies in which the murine
Sftpc promoter was used to drive diphtheria toxin receptor and
specifically deplete alveolar type II cells (16). Previously, the
mouse Scgbla1 promoter was used to drive expression of the
herpes simplex virus thymidine kinase gene (CCSP-TK) in
bronchiolar epithelial cells (2). Repeated administration of
ganciclovir in the CCSP-TK mouse model resulted in selective
ablation of CCSP-expressing cells. However, these animals
began dying 12 days after ganciclovir exposure, thus limiting
studies of bronchiolar regeneration and fibrosis after chronic
injury (2, 6).
We did not observe expression of SNAIL, SLUG, and
TWIST, transcription factors associated with EMT, in regions
of peribronchiolar fibrosis or intrabronchiolar lesions. EMT can
be observed in many adult tissues, and studies support a role for
Figure 10. Lack of epithelial–mesenchymal
transition (EMT) markers in fibrotic lesions.
Immunohistochemistry for (A, D, and G) SLUG,
(B, E, and H ) SNAIL, and (C, F, and I ) TWIST was
performed on lung sections of triple transgenic
mice after 10 days of diphtheria toxin A (DT-A)
expression (A–F ) and on urethane-induced lung
tumors (G–I ), which were used as positive
controls for the antibody staining. SLUG, SNAIL,
and TWIST staining was not detected in areas
with peribronchiolar fibrosis or in fibrotic cal-
luses. Results are representative of n > 3 triple
transgenic Scgb1a1/DT-A mice at all acute and
chronic injury and recovery time points.
Figure 11. Schematic process of lung injury and repair
after acute and chronic Clara cell depletion. Diphtheria
toxin A (DT-A) was expressed in Clara cells after doxycy-
cline (dox) treatment causing death of nonciliated cuboi-
dal cells. After acute epithelial injury (2 d of DT-A
expression), the remaining ciliated cells were squamous
and covered the basement membrane. From 2 to 10 days
after cessation of DT-A expression, the bronchiolar epi-
thelium proliferated and differentiated. Acute injury did
not cause stromal thickening. In contrast, after chronic
injury (10 d of DT-A expression) squamous metaplasia and
peribronchiolar fibrosis were observed. Squamous meta-
plasia, fibroblast proliferation, and excessive matrix de-
position were associated with peribronchiolar fibrosis.
Regional loss of epithelial integrity was associated with
intrabronchiolar lesions, ineffective epithelial regenera-
tion, and aberrant tissue repair. ECM 5 extracellular
matrix.
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EMT in response to lung injury (17). A Cre–lox approach for
lineage tracing with b-galactosidase was used to demonstrate
that epithelial cells undergo EMT in models of pulmonary
fibrosis involving overexpression of transforming growth factor-
b or insulin-like growth factor–binding protein-5 (56–58) and
after administration of the chemotherapy agent bleomycin (14,
15). Lineage-tracing studies in our transgenic model are limited
because cells expressing Cre are killed by the subsequent acti-
vation of the DT-A transgene, and thus the role of EMT in
fibrotic peribronchiolar regions can only be ascertained in-
directly. On the basis of our findings we speculate that the
bronchiolar fibrosis in this model is due to proliferation of
resident fibroblasts rather than transdifferentiating epithelial
cells that have escaped DT-A–mediated cell death to undergo
EMT. This mouse model of chronic Clara cell depletion should
be useful to study the pathogenesis of fibrosis after the loss of
epithelial integrity, and should facilitate studies to promote
epithelial regeneration and to prevent ineffective epithelial
regeneration and aberrant tissue repair.
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